Skip to main content
. 2022 Dec 7;10(12):3159. doi: 10.3390/biomedicines10123159

Table 4.

Outcome comparison of this meta-analysis with Piccolo et al. 2022 IPDM in ACS.

Study N Total N (%) with ACS
SPIRIT I [47] 56 Total: 9 (16.1%)
unstable angina: 9
ENDEAVOR II [48] 1197 Total: 359 (30%)
unstable angina: 359
PAINT [49] 491 Total: 90 (18.3%)
unstable angina: 90
BASKET PROVE [50] 2314 Total: 1492 (64.5%)
unstable angina: 754
STEMI: 738
CORACTO [51] 91 not reported
ISAR-CABG [52] 610 Total: 239 (39.2%)
unstable angina: 239
PRODIGY [53] 2003 Total: 1465 (73.1%)
unstable angina: 367
STEMI: 450
NSTEMI: 648
INSPIRON [54] 57 Total: 13 (22.8%)
unstable angina: 13
XIMA [55] 740 not reported
BASKET PROVE II [56] 2291 Total: 1446 (63.1%)
unstable angina: 787
STEMI: 659
LEADERS-FREE [57] 2442 Total: 1029 (42.1%)
unstable angina: 370
NSTEMI: 554
STEMI: 105
ZEUS [58] 1606 Total: 1016 (63.3%)
unstable angina: 270
NSTEMI: 441
STEMI: 305
NORSTENT [59] 9013 Total: 6319 (70.1%)
unstable angina: 1105
NSTEMI: 2842
STEMI: 2372
SENIOR [60] 1200 Total: 544 (45.3%)
unstable angina: 109
NSTEMI: 308
STEMI: 127